FLDDW
Fold Holdings, Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.27
52W High
$0.98
52W Low
$0.08
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-218.90%
Forward P/E
—
PEG Ratio
—
About Fold Holdings, Inc. Warrant
Fold Holdings, Inc. Warrant is a biotechnology firm dedicated to pioneering therapeutic solutions for rare genetic diseases, emphasizing innovation and unmet medical needs in healthcare. The company boasts a promising pipeline of proprietary drug candidates that are progressing through clinical trials, highlighting its commitment to research and development excellence. For institutional investors, Fold Holdings presents a compelling opportunity for growth and diversification within the dynamic biopharmaceutical sector, particularly as it aims to transform the treatment landscape for under-addressed conditions.
Fundamentals
| Revenue (TTM) | $31.79M |
| Gross Profit (TTM) | $-15.59M |
| EBITDA | $-28.22M |
| Operating Margin | -90.20% |
| Return on Equity | 278.60% |
| Return on Assets | -12.80% |
| Revenue/Share (TTM) | $0.75 |
| Book Value | $1.30 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 1622.00% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | 0 |
| Float | $5.17M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/2/2026